Ayurveda tech startup NirogStreet snaps up $12M in Sequence B funding
NirogStreet, an Ayurveda know-how platform in India, has scored $12 million in a Sequence B funding spherical led by Jungle Ventures.
It offers a neighborhood for Ayurveda docs and an e-commerce platform that streamlines the availability chain of Ayurvedic companies and medication. NirogStreet has onboarded round 50,000 medical practitioners and about 50 Ayurveda manufacturers.
The startup will use the proceeds from its newest investing spherical to bolster its provide chain, know-how, and companies.
Males’s well being startup Bonatra obtains pre-seed funding
Bonatra, a males’s health-focused startup from India, has raised INR 55 million ($670,000) in a pre-seed funding spherical led by ITI Development Alternatives Fund with the participation of marquee angel buyers, Jitendra Jagadev, founding father of Nestaway, and Blackbuck founder Rajesh Yabaji.
The corporate runs a know-how platform that provides personalised well being programmes focusing on continual circumstances of males.
In a press release, Bonatra stated that its contemporary funds might be used to develop its choices, construct its staff, and develop its shopper base.
Edenlux introduces AI report back to its cellular eye well being app
South Korean medical machine maker Edenlux is now offering AI-generated eye well being administration experiences by its flagship cellular app Otus Plus.
The app permits customers to check their eye well being with a paired goggle machine, do gamified eye workouts, and obtain a watch well being report.
Its eye well being experiences now include AI-generated eye well being scores, evaluation of eye focus response velocity, and outcomes of eye train video games based mostly on customers’ information.
Sooner or later, Edenlux plans so as to add an enchancment indicator to its experiences, in addition to provide a service that enables customers to decide on their very own customised lenses for eye workouts and use gathered information to offer a watch well being rating report.
Cha Vaccine ties up with MOGAM for AI drug discovery
The MOGAM Institute for Biomedical Analysis has signed a memorandum of understanding with the Cha Vaccine Institute for AI drug discovery.
They’ll cooperate to develop new medication and enhance drug substances utilizing MOGAM’s AI algorithms, which might be examined utilizing medical information from Cha Vaccine. Later, they’ll conduct joint research and apply for co-patents.